Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP vs IV Ondansetron for PONV in Laparoscopic Gynecological Surgeries
NCT05317611Completed
- Sponsor
- Zagazig University
- Start
- Jul 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ondansetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Zagazig University. Primary endpoints: Incidence of postoperative nausea and vomiting and Severity of postoperative nausea and vomiting. Started Jul 2022; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05317611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05317611.